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[57] ABSTRACT
A drug detecting apparatus including a chromato-
graphic system for separating a particular substance
from a sample solution passed therethrough, a source
of radiation for irradiating the separated substance as
it moves through the chromatographic system and for
causing it to fluoresce .and emit fluorescent radiation,
an optical system for spectrally separating the fluores-
cent radiation according to wavelength and for focus-
ing particular portions of the separated spectrum
through an exit aperture, a photodetector responsive
to radiation passing through the exit aperture and op-
erative to develop an electrical signal commensurate
with the intensity of such radiation, and a recorder re-
sponsive to the electrical signal and operative to pro-
vide an indication of certain characteristics of the sub-
stance.
The invention described herein was made by
employees of the United States Government and may
be manufactured and used by or for the Government
for governmental purposes without the payment of
any royalties thereon or therefor.
10 Claims, 2 Drawing Figures
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CHROMATO-FLUOROGRAPHIC DRUG
DETECTOR
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to drug detec-
tion apparatus and more particularly to a novel self-
scanning chromato-fluorographic drug detector which
combines the chemical and optical properties of chro-
matography and spectrofluorometry with an optical
readout system to provide a low cost, easy to operate,
portable analytical drug detection instrument.
2. Description of the Prior Art
Although detection and quantization of the chemical
constituents of various fluids has historically been done
in a laboratory, there are today many cases in which it
is desirable that means be available for providing an on-
the-spot test. In the narcotics enforcement field for ex-
ample, it is desirable for an arresting officer to have at
his immediate disposal a suitable detection means for
determining whether or not a suspect has ingested
drugs.
Current methods used for the detection and determi-
nation of morphine in' biological fluids involve the use
of wet chemistry, thin layer chromatography, gas liquid
chromatography, infrared techniques, electron spin
resonance, and fluorescence spectrometry. Several
commercially available instruments utilize one of the
above methods to determine morphine in urine. How-
ever, such instruments usually are quite expensive and
in most cases, require the use of laboratory facilities.
SUMMARY OF THE PRESENT INVENTION
It is therefore a principle object of the present inven-
tion to provide an analytical instrument of the type de-
scribed for detecting certain chemicals in biological
fluids while at the same time having the advantages of
being portable, or providing direct readout and of
being free from error due to potentially interferring
compounds.
Briefly, the present invention utilizes a chromato-
graphic column to separate the desired compound from
a biological sample and a spectro-fluorometer for de-
veloping a time spectral trace of the desired compound
as it passes through the column. The apparatus includes
an ultraviolet lamp and optical filter for irradiating the
separated compound and causing it to fluoresce as it
moves through the column, a fixed grating for spec-
trally separating the fluorescent radiation, a lens system
for collecting and focusing the rays of the spectrum, a
photo-diode detector for detecting the luminous inten-
sity of the rays of the spectrum, and a simple strip chart
recorder for recording the spectral data.
Among the advantages of the present invention is
that it provides an analytical instrument which is sub-
stantially less expensive than prior art devices, one
which is readily portable so as to permit on-the-spot
analysis of biological fluids, and one which permits the
measurement of at least two characteristic parameters
of the subject material.
These and other objects of the present invention will
no doubt become apparent to those skilled in the art
after having read the following detailed description of
a preferred embodiment which is illustrated in the sev-
eral figures of the drawings.
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IN THE DRAWINGS
FIG. 1 is a schematic diagram illustrating the princi-
ple operative components of a chromato-fluorographic
5 drug detector in accordance with the present invention;
and
FIG. 2 is a diagram illustrating a time-spectral trace
produced by the apparatus shown in FIG. 1 as a fluores-
cent band of separated compound moves through the
10 scanning region of the chromatographic column.
DETAILED DESCRIPTION OF THE PREFERRED
EMBODIMENT
Referring now to FIG. 1 of the drawing, a schematic
15 diagram of a drug detecting apparatus in accordance
with the present invention is shown which includes a
chromatographic system 10, a source of ultraviolet ra-
diation 12, a spectrally selective optical system 14, a
photo-detector 16, an amplifier 18, and a recorder 20.
20 Chromatographic system 10 in the preferred embodi-
ment includes a suitable developing solvent(s) 22, an
injection block 24 for permitting a sample to be intro-
duced into the chromatographic system which consists
of column 26 having a cylindrical casing 27 which is
25 packed with granular adsorbing material as is well
known in the art and having at least a section 28 which
is transparent to ultraviolet radiation and fluorescent
radiation and which may be referred to as a scanning
region or detection region.
30
 The column 26 is of a length suitable to permit a par-
ticular type of sample to be separated into a narrow
band B by the time the compound in question has tra-
versed the column into the scanning region 28. The
casing 27 has a number of masking strips 30 disposed
35 in partially circumscribing, spaced-apart relationship
on its surface as indicated. The strips 30 are equally
spaced along the length of casing 27 and are preferably
of a width at least as great as the maximum expected
width of the band of separated sample compound B as
1° -it moves through the scanning region 28 of coIumn-26.
The monochromatic source of ultraviolet radiation
12 may include any suitable type of ultraviolet lamp 32
and filter 34 along with means (not shown) for focusing
the ultraviolet radiation onto at least the scanning re-
gion so as to cause any fluorescent material passing
therethrough to fluoresce.
Optical system 14 includes a reflector such as the sil-
vered mirror 36 which is positioned relative to the
scanning region 28 so as to reflect fluorescent radiation
upwardly as illustrated. The reflected radiation is col-
lected by a collimating lens system 38 focused onto a
fixed diffraction grating 40 which causes the light beam
to be separated into its component colors and reflected
back into lens 38. Lens 38 then collects and focuses a
particular portion of the spectrum back through a suit-
able aperture, such as the slit 42, onto detector 16.
Detector 16 may include a photo-sensitive device,
,Q such as a photo-diode or the like, which develops an
electrical output signal at 44 having a magnitude pro-
portional to the intensity of the radiant energy imping-
ing upon its light sensitive surface. Amplifier 18 is pro-
vided to amplify the output signal developed by detec-
65 tor 16 to a level suitable for driving recorder 20. Re-
corder 20 in the preferred embodiment includes a strip
chart recording device but may alternatively include a
meter, indicator, alarm or other device capable of pro-
45
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viding a desired indication or response to the detected
substance. It will also be appreciated that the optical
system 14 may alternatively include a suitable prism
type of dispersion apparatus or any other device capa-
ble of separating the fluorescent radiation developed
by the fluorescing substance into its spectral compo-
nents.
In operation, a liquid solution(s) is caused to flow
from source 22 (note that 22 may represent one or sev-
eral bottles containing developing solvents, buffered
reagents, and fluorogenic reagents which react rather
spectifically with, perhaps, a non-fluorescent com-
pound to yield a derivative which becomes fluorescent
before passing the scanning region 28) through mixer
block 24 and chromatographic column 26. A sample
quantity of test fluid containing the compound to be
detected is injected into the stream through block 24.
As the sample moves through column 26, the particular
substance of interest will separate and move through
the column in a disc-like band.
Upon moving into the scanning region 28, radiation
from lamp 32 causes the band of separated substance
to fluoresce thus forming a source of radiation which
moves at a predictable rate (rate known by use of inter-
nal standards or known reproducibility under a specific
and controlled chemical and physical environment)
through the region 28. When the substance first enters
the scanning region, mirror 36 reflects the fluorescent
radiation onto diffraction grating 40 at an angle which
causes a particular portion of the dispersion spectrum
to be reflected back through collimating lens 38 and
past the silvered mirror 36. Lens 38 causes certain
wavelengths of the spectrally separated light rays to be
focused through slit 42 and onto detector 16. Upon
sensing the intensity of the radiation then passing
through slit 42, detector 16 develops an electrical sig-
nal which is amplified by amplifier 18 and input to re-
corder 20 where its amplitude is recorded.
As the substance moves through the detection re-
gion, it will be noted that the angle of incidence of radi-
ation upon mirror 36 changes, and likewise the angle
of incidence of the radiation upon the fixed grating 40
changes. Accordingly, the effect of passage of band B
through region 28 will be equivalent to a scanning of
the spectrum of radiation emitted from the fluorescent
band.
Since the several masks 30 are arranged at fixed posi-
tions along the column and the column is fixed in posi-
tion relative to the optical system, each mask position
corresponds to a particular wavelength, and the inter-
ruptions ofthe time spectral trace produced as the fluo-
rescent band is obscurred by each mask, thereby pro-
vides a spectral calibration point which relates the
chart position directly to spectral wavelength. From the
known distance between the masks 30 and the chart
speed of the recorder, the rate of movement of the
band can be calculated accurately. Thus, the present
apparatus provides a means for measuring the fluores-
cent spectrum characteristic of the fluorescing sub-
stance, the rate of movement ofthe band down the col-
umn to further confirm the compound type, and the
spectral amplitude which provides a quantitative mea-
sure of the particular compound present in the urine
specimen. Furthermore, these measurements are made
simultaneously.
The present application has particular utility for mea-
suring drugs such as morphine appearing in urine speci-
10
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mens since chemical treatment of the specimen can
convert the weakly fluorescent morphine into a highly
fluorescent fluorophore. After treatment, the sample
can be very simply introduced into the chromato-
graphic column 26 via injection block 24. The most
sensitive morphine fluorophore compounds capable of
identification by spectral photometric techniques are
those that can be formed in aqueous solutions and pref-
erably those in which the chemical reactions can be
carried out in urine with a minimum of manipulations.
It has, for example, been demonstrated that pseudo-
morphine and dansylmorphine are highly fluorescent
compounds which can be formed in aqueous solutions
on solid supports. However, other non-aqueous solu-
tions may also be used provided the transfer of mor-
phine from the aqueous to the non-aqueous phase can
be accomplished quickly and efficiently. Colorometric
derivatives or complexes of morphine may also be used
if they are also fluorescent. Other morphine derivatives
which can be formulated for measurement are:
1. The dimer of morphine, pseudomorphine,
2. The reaction product of 1-napthalene sulfonye
chloride-5-dimethylamino (dansylchloride) and
morphine,
3. The reaction product of lissamine Rodamine B
(RB200), its sulfonylchloride, and morphine,
. 4. The diazonium salt of aminorosamine or other
suitable amino fluorochrome with morphine,
5. The morphine fluorophore as prepared by Mule
and Hushin, Analytical Chemistry, 43, No. 6, pp.
708-711(1971),
6. The reaction product of morphine with the Mar-
quis reagent,
7. The reaction product of 3-phenyl-7-
isocyanatocoumarin with morphine.
The present invention provides an analytical instru-
ment which will cost about 5-10 times less than any
machine presently available. The instrument can be
made readily portable to provide for on-the-spot analy-
sis and is one which is capable of providing at least two
characteristic parameters, one of which is the measure
of a molecular property of the morphine fluorophore,
i.e., its fluorescent spectrum.
The instrument is a self scanning device in that it has
an optical readout system with no moving parts and
uses the moving fluorescent band as a moving light
source to yield a scan of the emission spectrum of the
morphine fluorophore which may be recorded on a
simple strip chart recorder. Such an instrument can be
used for any fluorescent compound or its fluorescent
derivative for which an appropriate chromatographic
system can be designed. Other compounds such as cer-
tain vitamins and the amphetimine drugs, and many
other aromatic drugs and food additives can also be de-
tected and measured with an appropriately modified
instrument.
The present invention is believed to be the first de-
vice of its type which is capable of simultaneously
yielding at least two characterizing properties of mor-
phine or one of its derivatives, i.e., the migration rate
through a chromatographic system under a controlled
and specific chemical environment, and the fluores-
cence spectrum of the morphine fluorophore, which is
a molecular property and can be used for confirmatory
evidence in legal matters. The instrument is believed to
have extensive application in both the forensic and
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medical fields for detection of heroin and other danger-
ous drugs.
Although but a single preferred embodiment of the
present invention has been disclosed herein, it will be
apparent to those skilled in the art that many alter-
ations and modifications thereof can be made to imple-
ment the invention for use in a particular application.
It is therefore to be understood that the foregoing de-
scription is for purposes of illustration only, and the ap-
pended claims are to be interpreted as covering all such
alterations and modifications as fall within the true
spirit and scope of the invention.
What is claimed is:
1. Drug detecting apparatus, comprising:
a chromatographic system having a column for sepa-
rating a particular substance from a sample solu-
tion passed therethrough;
a source of radiation for irradiating the separated
substance as it moves through said chromato-
graphic column and for causing it to fluoresce and
emit fluorescent radiation;
optical means for spectrally separating said fluores-
cent radiation according to wavelength and for fo-
cusing particular portions of the separated spec-
trum through an exit aperture;
detecting means responsive to radiation passing
through said exit aperture and operative to develop
an electrical signal commensurate with the inten-
sity of such radiation; and
means responsive to said electrical signal and opera-
tive to provide an indication of certain characteris-
tics of said substance.
2. Drug detecting apparatus as recited in. claim 1
wherein said optical means includes a reflector, a lens
system, diffraction grating and means forming said exit
aperture, said reflector being operative to reflect said
fluorescent radiation through said lens system and onto
said grating, said grating being operative to spectrally
separate said radiation and direct the separated rays
back-into said lens system wherein rays'of particular
wavelengths are collected by said lens system and fo-
cused onto said aperture forming means, whereby
movement of the fluorescing substance through said
column causes the spectrum to sweep across said exit
aperture so that the portions of the spectrum passing
through said aperture change in proportion to the posi-
tion of the substance in said column.
3. Drug detecting apparatus as recited in claim 1
wherein said chromatographic system includes an ad-
sorption column having a section transparent to said
fluorescent radiation, said section being provided with
opaque masks disposed in spaced apart relationship
along the path to be followed by said substance as 'it
passes through said column and for blocking radiation
from said optical means as said substance passes behind
said masks.
4. Drug detecting apparatus as recited in claim 3
wherein said section is generally cylindrical in configu-
ration and said opaque masks include opaque strips at
least partially circumscribing said section, said strips
having a width at least as large as the maximum longitu-
dinal length of the separated substance when it passes
through said section.
5. Drug detecting apparatus as recited in claim 4
wherein said optical means includes a reflector, a lens
system, diffraction grating and means forming said exit
aperture, said reflector being operative to reflect said
fluorescent radiation through said lens system and onto
said grating, said grating being operative to spectrally
separate said radiation and direct the separated rays
5 back into said lens system wherein rays of .particular
wavelengths are collected by said leris system and fo-
cused onto said aperture forming means, whereby
movement of the fluoresing substance through said col-
umn causes the spectrum to sweep across said exit ap-
10 erture so that the portions of the spectrum passing
through said aperture change in proportion to the posi-
tion of the substance in said column.
6. Drug detecting apparatus as recited in claim 1
wherein said optical means includes a diffraction grat-
15 ing which is operative to spectrally separate said radia-
tion so that a single portion of the radiation spectrum
may be projected through said exit aperture at a partic-
ular point in time.
7. Drug detection apparatus as recited in claim 6
20
 wherein said detecting means includes a photodetector
positioned externally of said exit aperture for receiving
the portion of said spectrum passing through said aper-
ture, and wherein said means responsive to said electri-
cal signal includes a strip chart recorder for providing
25
 a time vs. signal-amplitude record.
8. Drug detecting apparatus, comprising:
a chromatographic system for separating a particular
substance from a sample solution passed there-
through and including an adsorption column hav-
ing a section transparent to fluorescent radiation;30
35
a source of radiation for irradiating the separated
substance as it moves through said transparent sec-
tion and for causing said substance to fluoresce and
emit fluorescent radiation;
optical means for separating said fluorescent radia-
tion according to wavelength and for focusing par-
ticular portions of the separated spectrum through
40— -an exit-aperture; —
detecting means responsive to radiation passing
through said exit aperture and operative to develop
an electrical signal commensurate with the inten-
sity of such radiation; and
45 means responsive to said electrical signal and opera-
tive to provide an indication of certain characteris-
tics of said substance.
9. Drug detecting apparatus as recited in claim 8
wherein said optical means includes a diffraction grat-
50 ing for receiving and spectrally separating said fluores-
cent radiation, means forming said exit aperture, and a
lens system for focusing the spectrally separated rays
onto said aperture forming means, whereby movement
of the fluorescing substance through said section
55 causes the spectrum to sweep across said exit aperture
so that the portions of the spectrum focused upon said
aperture change in proportion to the position of the
substance in said column.
10. Drug detecting apparatus as recited in claim 9
60 wherein said section is generally cylindrical in configu-
ration and is provided with opaque masks disposed in
spaced apart relationship along the path followed by
said substance as it passes through said column, said
masks being operative to block radiation from said op-
65 tical means as said substance passes behind said masks.

